Home Intrauterine Diabetic Environment Confers Risks for Type 2 Diabetes Mellitus and Obesity in the Offspring, in Addition to Genetic Susceptibility
Article
Licensed
Unlicensed Requires Authentication

Intrauterine Diabetic Environment Confers Risks for Type 2 Diabetes Mellitus and Obesity in the Offspring, in Addition to Genetic Susceptibility

  • Dana Dabelea EMAIL logo and David J. Pettitt
Published/Copyright: October 11, 2016

Abstract

Numerous studies have reported that offspring whose mothers had type 2 diabetes mellitus (DM) are more likely to develop type 2 DM, impaired glucose tolerance, and obesity at an early age than offspring whose fathers had DM. Exposure to the diabetic intrauterine environment has been shown to be an important risk factor for all these conditions. To what extent transmission of type 2 DM from mother to offspring is the effect of genetic inheritance and to what extent it is the long-term consequence of exposure to maternal hyperglycemia is still uncertain. There are, of course, interactions between the diabetic intrauterine environment and genetics. Several data in experimental animals as well as in humans suggest, however, that exposure of the fetus to the mother’s DM confers a risk for type 2 DM and obesity that is above any genetically transmitted susceptibility. In the Pima Indian population much of the increase in childhood type 2 DM can be attributed to the diabetic intrauterine environment. This suggests that intensive glucose control during pregnancy might have extended beneficial effects, contributing to a decrease in the prevalence of childhood type 2 DM.

Published Online: 2016-10-11
Published in Print: 2001-9-1

© 2016 by Walter de Gruyter Berlin/Boston

Articles in the same Issue

  1. Titelei
  2. Table of Contents
  3. Doping with Growth Hormone
  4. Intrauterine Diabetic Environment Confers Risks for Type 2 Diabetes Mellitus and Obesity in the Offspring, in Addition to Genetic Susceptibility
  5. Variable Presentation of X-linked Adrenal Hypoplasia Congenita
  6. Sustained Benefits of Growth Hormone on Body Composition, Fat Utilization, Physical Strength and Agility, and Growth in Prader-Willi Syndrome are Dose-Dependent
  7. Insufficient Adrenarche in Patients with Combined Pituitary Hormone Deficiency Caused by a PROP A Gene Defect
  8. Syndrome of Congenital Adrenocortical Unresponsiveness to ACTH. Report of Six Patients
  9. Maternal and Fetal Serum Insulin-like Growth Factor-I (IGF-I), IGF Binding Protein-3 (IGFBP-3), Leptin Levels and Early Postnatal Growth in Infants Born Asymmetrically Small for Gestational Age
  10. Relationships Between Levels of Leptin and Hematological Parameters in Healthy Term Infants
  11. Recombinant Growth Hormone Treatment in Short Patients with Thalassemia Major: Results after 24 and 36 Months
  12. Assessment of the Current Status of Iodine Prophylaxis in Bosnia and Herzegovina Federation
  13. Profiles of Obese Children Presenting for Metabolic Evaluation
  14. Effect of Growth Hormone Treatment on Hypoglycemia in a Patient with both Hepatic Glycogen Synthase and Isolated Growth Hormone Deficiencies
  15. Gliclazide-Induced Hepatitis, Hemiplegia and Dysphasia in a Suicide Attempt
  16. Neonatal Goiter Caused by Expectorant Usage
  17. Idiopathic Hypothalamic Dysfunction with Precocious Puberty and Adipsic Hypernatremia First Presenting in Adolescence
  18. Neonatal Hyperthyroidism m Infants of Mothers Previously Thyroidectomized due to Graves’ Disease
  19. Primary Hyperparathyroidism in an Infant with Three Parathyroid Glands and Pulmonary Calcinosis
  20. Asymmetric Crying Facies and Congenital Hypothyroidism: Report of Two Patients
  21. Obituary. Professor Dr. Andrea Prader (1919–2001)
  22. Meetings Calendar
  23. Author Index
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2001-0803/pdf
Scroll to top button